Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
LFB is a French biopharmaceutical group that develops, manufactures, and markets medicinal products for the treatment of serious and often rare diseases in key therapeutic areas including immunology, hemostasis, and intensive care. With a strong focus on innovation, LFB leverages its expertise in plasma-derived medicines and recombinant proteins to provide healthcare solutions to patients worldwide. The company is committed to high standards of quality and safety in its bioproduction processes.
Serves as LFB's global corporate center, housing key administrative, strategic, R&D, and commercial operations leadership. It coordinates the group's activities in biopharmaceutical development and production.
Located in the Courtaboeuf European Science and Technology Park, a major hub for innovation. The facilities likely include modern office spaces and potentially research laboratories.
A dynamic environment focused on scientific excellence, patient well-being, ethical conduct, and collaborative innovation in the biopharmaceutical field. Emphasis on quality and safety in all operations.
Central to LFB's strategic direction, research initiatives, and international market coordination. Its location facilitates collaboration with other tech and research entities within a prominent science park.
LFB markets its products in over 30 countries worldwide, either through its own subsidiaries (e.g., in the USA, Germany, UK, Spain, Italy, Belgium, Turkey, Brazil) or via a network of distribution partners. Its global functions encompass the entire biopharmaceutical value chain: research and development, support for plasma collection, advanced biomanufacturing of plasma-derived and recombinant medicines, conducting international clinical trials, managing regulatory submissions across diverse jurisdictions, and commercial operations tailored to local healthcare systems. This global reach ensures access to LFB's critical therapies for patients with serious and rare diseases across Europe, the Americas, Asia, and other regions.
3 Avenue des Tropiques, ZA de Courtaboeuf
Les Ulis
Essonne
France
Address: Parc scientifique et technologique Agroparc, Alès (Address may vary for specific LFB Biomanufacturing site)
Supports LFB's global production capacity, particularly for plasma-based treatments, and contributes to regional economic development in the advanced biomanufacturing sector.
Address: Parc Eurasanté Est, Loos (Lille) and a new facility in Arras (Specific addresses for manufacturing plants)
Enhances LFB's capabilities in biotechnology and next-generation therapy production, strengthening its position in the European biopharmaceutical landscape and increasing production autonomy.
Address: LFB USA Inc., 175 Crossing Boulevard, Suite 410, Framingham, MA 01702
Crucial for accessing the significant US pharmaceutical market, conducting clinical trials, and making LFB's specialized therapies available to American patients.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, LFB' leadership includes:
LFB has been backed by several prominent investors over the years, including:
LFB underwent a key leadership change in the past year with the appointment of a new Chief Executive Officer, signaling a new phase for the company's strategic direction and operational focus.
Discover the tools LFB uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
LFB likely uses standardized email formats for its employees, typically combining parts of the employee's name with the company domain 'groupe-lfb.com'. Common corporate email patterns include [first_initial][last_name]@[domain] or [first_name].[last_name]@[domain]. Using these formats can increase the chance of reaching the intended recipient for professional communication.
[first_initial][last_name]@groupe-lfb.com (e.g., jdoe@groupe-lfb.com) or [first_name].[last_name]@groupe-lfb.com (e.g., jane.doe@groupe-lfb.com)
Format
jbrom@groupe-lfb.com
Example
80%
Success rate
LFB Press Release • 2023-09-06
LFB announced the appointment of Jacques Brom as its new Chief Executive Officer, effective September 6, 2023. He succeeds Denis Delval and is tasked with leading LFB's continued development and strategic growth in the biopharmaceutical sector, leveraging his strong experience in the pharmaceutical industry....more
LFB Press Release • 2023-02-28
LFB successfully completed a €200 million capital increase, subscribed by the French State (its majority shareholder) and Bpifrance. This funding is intended to support LFB's strategic plan 'Ambition 2025', particularly its industrial projects, including the construction of a new manufacturing plant in Arras, and its international development....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including LFB, are just a search away.